Neuromuscular blocking agents and reversal agents

被引：0

作者：

Ahmad, Shahzaib ^{[1
]}

Handslip, Rhodri ^{[1
]}

机构：

[1] St Georges Univ Hosp NHS Trust, Intens Care Med, London, England

来源：

ANAESTHESIA AND INTENSIVE CARE MEDICINE | 2024年 / 25卷 / 09期

关键词：

Acetylcholine; aminosteroid; benzylisoquinolinium; neostigmine; neuromuscular blocking drugs; neuromuscular junction; succinylcholine; sugammadex;

D O I：

10.1016/j.mpaic.2024.07.001

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

The neuromuscular junction is a complex structure consisting of the muscle cell, the nerve terminal of a motor neuron and the synaptic cleft. It is the site of action for neuromuscular blocking drugs, which are a cornerstone of anaesthetic practice. These drugs can be divided into depolarizing and non-depolarizing drugs; the latter can be further subdivided into benzylisoquinolinium and aminosteroid compounds. Reversal agents are also discussed. The pharmacology of neuromuscular blocking drugs and reversal agents is discussed including mechanism of action, metabolism, factors influencing choice of drug as well as adverse effect profile.

引用

页码：595 / 599

页数：5

共 50 条

[31] A New Agent to Reverse the Effects of Benzylisoquinoline and Steroidal Neuromuscular-blocking Agents [J].

Hoffmann, Ulrike ;

Grosse-Sundrup, Martina ;

Eikermann-Haerter, Katharina ;

Zaremba, Sebastina ;

Ayata, Cenk ;

Zhang, Ben ;

Ma, Da ;

Isaacs, Lyle ;

Eikermann, Matthias .

ANESTHESIOLOGY, 2013, 119 (02) :317-325

[32] Clinical uses and controversies of neuromuscular blocking agents in infants and children [J].

Martin, LD ;

Bratton, SL ;

O'Rourke, PP .

CRITICAL CARE MEDICINE, 1999, 27 (07) :1358-1368

[33] Dosing of neuromuscular blocking agents in patients with obesity: A narrative review [J].

Erstad, Brian L. ;

Barletta, Jeffrey F. .

ANAESTHESIA AND INTENSIVE CARE, 2021, 49 (02) :98-104

[34] Cardiac Arrest and Neuromuscular Blockade Reversal Agents in the Transplanted Heart [J].

Bertolizio, Gianluca ;

Yuki, Koichi ;

Odegard, Kirsten ;

Collard, Vincent ;

DiNardo, James .

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2013, 27 (06) :1374-1378

[35] Residual neuromuscular block in the postanesthesia care unit: incidence, risk factors, and effect of neuromuscular monitoring and reversal agents [J].

Ozbey, Nazli Bahar ;

Abdullah, Taner ;

Deligoz, Ozlem .

TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (05) :1656-1664

[36] Post-junctional interactions between neuromuscular blocking agents and ethanol at the mouse neuromuscular junction [J].

Searl, T. J. ;

Silinsky, E. M. .

BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (03) :659-667

[37] Flexible organic frameworks sequester neuromuscular blocking agents in vitro and reverse neuromuscular block in vivo [J].

Wu, Yan ;

Liu, Yue-Yang ;

Liu, Hong-Kun ;

Yu, Shang-Bo ;

Lin, Furong ;

Zhou, Wei ;

Wang, Hui ;

Zhang, Dan-Wei ;

Li, Zhan-Ting ;

Ma, Da .

CHEMICAL SCIENCE, 2022, 13 (32) :9243-9248

[38] Systematic Evaluation of Neuromuscular Reversal Agents in Obese Patients After General Anesthesia for Bariatric Surgery [J].

Wang, Mengxia ;

Li, Shuai ;

Jiang, Hongxue ;

Yu, Wei ;

Hu, Donghua ;

Duan, Shan'e ;

Tang, Jieke ;

Li, Yalan .

BARIATRIC SURGICAL PRACTICE AND PATIENT CARE, 2023, 18 (04) :248-254

[39] Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study [J].

Domenech, Gonzalo ;

Kampel, Matias A. ;

Garcia Guzzo, Maria E. ;

Sanchez Novas, Delfina ;

Terrasa, Sergio A. ;

Garcia Fornari, Gustavo .

BMC ANESTHESIOLOGY, 2019, 19 (01)

[40] Molecular mechanisms of neuromuscular blocking agents: Is the increased understanding of importance to the practising anaesthetist? [J].

Aglan, MY ;

Pollard, BJ .

PHARMACOLOGY & THERAPEUTICS, 1995, 68 (03) :365-383

← 1 2 3 4 5 →